Clinical Trials on Inherited Metabolic Disorders (IMD)

Total 39317 results

Lund University
Ministry of Health and Social Affairs, Sweden

Completed

Postoperative Hyperglycemia After Knee Primary Knee Arthroplasty Surgery

Hyperglycemia

Sweden
Kyowa Kirin Co., Ltd.

Completed

Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia

Japan
Shire

Completed

Long-term Effect of Lanthanum Carbonate on Bone

Hyperphosphatemia

United States, Germany, United Kingdom
Zealand Pharma

Completed

Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children

Hypoglycemia

United States, Germany, Slovenia
Bayer

Completed

Fosrenol Post-marketing Surveillance for Hemodialysis in Japan (FOSRENOL-HD)

Hyperphosphatemia

Japan
Vifor Fresenius Medical Care Renal Pharma

Completed

Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) (VERIFIE)

Hyperphosphatemia

Spain, Netherlands, Germany, Italy, France, Greece, United Kingdom
Rambam Health Care Campus

Unknown

Antenatal Betamethasone and the Risk of Neonatal Hypoglycemia

Hypoglycemia

Israel
Federico II University

Completed

Metabolic Effects of High-amylose Wheat-based Rusks.

Hyperglycemia

Italy
Joslin Diabetes Center
Abbott Diabetes Care

Completed

Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery

Hypoglycemia

United States
Texas Woman's University

Completed

The Effects of Leucine and Isoleucine on Glucose Metabolism (AA+GLU)

Hyperglycemia
Bassett Healthcare

Completed

The Effect of Glucomannan Soluble Fiber on Glucose Homeostasis in Patients With Roux En Y (RNY) Gastric Bypass Surgery

Hypoglycemia
Jiujiang No.1 People's Hospital

Unknown

Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia (NAHPH)

Hyperphosphatemia

China
UNEEG Medical A/S

Terminated

Evaluation of Hypo-Safe Hypoglycaemia Alarm Device - a Pilot Study (Pilot)

Hypoglycemia

Denmark
Rijnstate Hospital

Completed

FGF-23 Suppressibility by Calcitonin

Hypophosphatemia

Netherlands
Zealand Pharma

Completed

Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon

Hypoglycemia

Germany
Biodel

Completed

Pharmacokinetics and Pharmacodynamics of BIOD-961 vs. Marketed Glucagons

Hypoglycemia
Robert R. Henry, MD
Veterans Medical Research Foundation

Completed

Somatostatin Analogue SOM230 (Pasireotide) in Healthy Male Volunteers (Pasireotide)

Hyperglycemia

United States
University of Eastern Finland
Kuopio University Hospital; VTT Technical Research Centre, Finland

Completed

The Effect of n-3 Fatty Acids and Fish on Glucose and Lipid Metabolism in Subjects With Impaired Glucose Metabolism

Hyperglycemia

Finland
OptiScan Biomedical Corporation
Erasme University Hospital

Completed

OptiScanner Versus Standard Blood Glucose Monitoring

Hyperglycemia

Belgium
University of Roma La Sapienza

Completed

Humalog or Humulin for Intensive Insulin Therapy in Intensive Care Unit

Hyperglycemia

Italy
Northwell Health
Staten Island University Hospital

Completed

Pre-admission Hyperglycemia and Its Effect on Morbidity and Mortality

Hyperglycemia

United States
Shiraz University of Medical Sciences

Completed

The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients

Hyperphosphatemia

Iran, Islamic Republic of
Bayer

Completed

BAY 77-1931 Long-term Extension From Phase II Study

Hyperphosphatemia

Japan
Shanghai Jiao Tong University School of Medicine
Baxter Healthcare Corporation

Unknown

The Effect of Systemic Dietary Instruction on Management of Plasma Phosphorus Levels in Peritoneal Dialysis (PD) Patients

Hyperphosphatemia

China
Atlantic Health System

Terminated

Evaluation of an ICU Hyperglycemia Protocol Using Insulin Aspart

Hyperglycemia

United States
Novo Nordisk A/S

Completed

Study Investigating Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophilia A Patients

Congenital Bleeding Disorder | Haemophilia A

Mexico
Novo Nordisk A/S

Terminated

A Multi-centre, Open Labelled, Multiple Dosing Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC 0172-2021 Administered Subcutaneously to Healthy Male Subjects and Haemophilia Subjects (explorer™2)

Healthy | Congenital Bleeding Disorder | Haemophilia A

Austria, Spain, United Kingdom, France, Germany
Novo Nordisk A/S

Completed

Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A (guardian ™9)

Congenital Bleeding Disorder | Haemophilia A

Austria, Spain, United States, Germany, Serbia, Taiwan, Bulgaria
Novo Nordisk A/S

Completed

A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A (pathfinder™7)

Congenital Bleeding Disorder | Haemophilia A

United States, Netherlands, Spain, Germany, France, Denmark
Novo Nordisk A/S

Completed

Observational Registry of the Treatment of Glanzmann's Thrombasthenia

Congenital Bleeding Disorder | Glanzmann's Disease

Spain, Bulgaria, Pakistan, Belgium, Germany, France, United Kingdom, Italy, Hungary, Netherlands, United States, Algeria, Austria, Sweden, Switzerland
Stanford University

Not yet recruiting

Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar Illness

Obesity | Metabolic Syndrome | Bipolar Disorder | Bipolar and Related Disorders | Bipolar Depression | Weight Gain | Bipolar I Disorder | Ketogenic Dieting | Bipolar Disorder I | Bipolar II Disorder | Psychotropic Agents Causing Adverse Effects in Therapeutic Use | Brain Metabolic Disorder | Bipolar Disorder, Type... and other conditions

United States
Providence VA Medical Center

Completed

Behavioral Activation Therapy for Both Depression and Diabetes Vs. Diabetes Alone Delivered Via Group Visits (BA-MEDIC)

Depression | Diabetes

United States
First Affiliated Hospital of Chongqing Medical...

Completed

Exploring Blood Plasma Metabolomics: Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression

Major Depressive Disorder | Psychiatric Disorder | Metabolic Disorder

China
University Health Network, Toronto

Recruiting

Brain Insulin Resistance in Mood Disorders

Anhedonia | Bipolar Disorder | Major Depressive Disorder | Intranasal Insulin

Canada
AstraZeneca
AstraZeneca K.K.

Recruiting

A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia (PURSUIT)

Dyslipidemia

Denmark, Hungary, Spain, United States, Japan, Czechia, Slovakia, Canada
Yonsei University

Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia

Dyslipidemia

Korea, Republic of
Dongkwang Pharm. Co., Ltd.

Not yet recruiting

Phase 3 Trial to Evaluate the Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A

Dyslipidemias
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507

Dyslipidemias
Adrian Vella
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics

Healthy

United States
Hospices Civils de Lyon

Recruiting

From Known to New Genes in Dyslipidemia (GENELIP)

Dyslipidemias

France
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391

Dyslipidemias

Korea, Republic of
Amgen

Completed

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension (FOURIER OLE)

Dyslipidemia

United States, Poland, Czechia, Hungary, Russian Federation, Ukraine, Slovakia
Abbott

Completed

A Clinical Study to Evaluate the Effect of Mobile Applications "My A:Care" and "Smart Coach" on the Lipid-lowering Treatment Adherence of Subjects With Dyslipidemia in Thailand (My A:Care)

Dyslipidemia

Thailand
Sun Yat-sen University

Completed

A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder

Dyslipidemias

China
Eli Lilly and Company

Completed

A Study of LY3561774 in Participants With Dyslipidemia

Dyslipidemias

United States
Kowa Company, Ltd.

Completed

A Phase III Long Term Study of K-877 Extended Release Tablet

Dyslipidemias

Japan
Dr. Anatoly Langer
Amgen

Active, not recruiting

GOAL International QuERI - Protocol CHRC 2019 GOAL INTERNATIONAL (GOAL QuERI)

Dyslipidemia

Kuwait, Mexico, Saudi Arabia, United Arab Emirates
Laboratorios Silanes S.A. de C.V.

Completed

Study to Evaluate the Safety of the Fixed-dose Combination Rosuvastatin/Ezetimibe for Patients With Dyslipidaemia (TREZETE)

Dyslipidemias

Mexico
Organon and Co

Completed

Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED)

Dyslipidemia
Yooyoung Pharmaceutical Co., Ltd.

Completed

Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A

Dyslipidemias

Korea, Republic of

3

Subscribe